4
Changes in Ownership
CNS Pharmaceuticals, Inc. Filed Acc 0001683168-23-006001
Chief Financial Officer bought 27,000 shares at $1.27 ($34,177)
From the SEC's structured data for this filing
Trades in this filing
Downs Christopher · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-08-22 | Purchase : show line 1 in the form | +27,000 | $1.27 | $34,177 | 36,772 | D |
| Open-market purchases · 27,000 sh · avg $1.27 · $34,177 | ||||||
Loading xslF345X05/ownership.xml…